Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.695 USD | +2.73% | +10.39% | +11.11% |
Apr. 30 | Leerink Partners Starts Lexicon Pharmaceuticals With Outperform Rating, $5 Price Target | MT |
Apr. 29 | Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.11% | 406M | |
-1.56% | 104B | |
+6.57% | 97.47B | |
+5.71% | 22.25B | |
-12.88% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.28% | 14.39B | |
+36.50% | 12.37B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals : Citigroup Upgrades Lexicon Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $6 From $2.10